Par Drugs And Chemicals
PAR · Chemicals > Chemicals · Chairman: Falgun Vallabhbhai Savani · MD: Falgun Vallabhbhai Savani · Listing date: May 16, 2019 · Employees: 92 · Bhavnagar · http://pardrugs.com

Stock Price vs Company Growth
1d
0.0%
1w
0.0%
1m
0.0%
3m
5.5%
6m
20.2%
1y
24.0%
5y
61.1%
all
41.8%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowMar21Dec21Sep22Jun23Mar24Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

188 0%
180
197
Company Overview

Sales
101 Cr
Growth: 12.9%
Profit after Tax
15.4 Cr
Growth: -15.6%
Micro Cap
231 Cr
P/E: 15.0x
Industry P/E: 26.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 101
Growth 12.9%
EBITDA 22.8%
P/S 2.3x
Dividend 0.0%
P/E 15.0x
Book Value ₹ 79.1
PEG Ratio 1.2x
ROE 16.8%
P/B 2.4x
Shareholding Pattern

Institutions
Sunita Ben Paragbhai Shah
1.92 %
Parag Jayantibhai Shah
1.14 %
Created with Highcharts 8.2.2Sep24
Promoters
Jignesh Vallabhbhai Savani
21.78 %
Falgun Vallabhbhai Savani
21.5 %
Vallabhbhai J Savani
19.46 %
Ghanshayambhai B Savani
6.41 %
Saritaben Vallabhbhai Savani
1.8 %
Created with Highcharts 8.2.2Sep24
Others
Created with Highcharts 8.2.2Sep24
Increase    Decrease    No change
Company Profile Detailed

:PDCL is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. It currently produce various range of Antacid Molecules which are available in the market and are in great demand.Key Events and Milestones:1999: Incorporated as a Private Limited Company with the name ‘Par Drugs and Chemicals Private Limited’.1999: Acquisition of the ongoing business of the M/s. Par In Organic.
Investors (5)